Skip to main content

3 Reasons to Sell CRI and 1 Stock to Buy Instead

CRI Cover Image

Over the past six months, Carter's has been a great trade, beating the S&P 500 by 10.2%. Its stock price has climbed to $34.80, representing a healthy 13.3% increase. This run-up might have investors contemplating their next move.

Is now the time to buy Carter's, or should you be careful about including it in your portfolio? See what our analysts have to say in our full research report, it’s free.

Why Do We Think Carter's Will Underperform?

Despite the momentum, we're swiping left on Carter's for now. Here are three reasons why CRI doesn't excite us and a stock we'd rather own.

1. Flat Same-Store Sales Indicate Weak Demand

We can better understand Consumer Discretionary - Apparel and Accessories companies by analyzing their same-store sales. This metric measures the change in sales at brick-and-mortar locations that have existed for at least a year, giving visibility into Carter’s underlying demand characteristics.

Over the last two years, Carter's failed to grow its same-store sales. This performance was underwhelming and implies there may be increasing competition or market saturation. It also suggests Carter's might have to change its strategy and pricing, which can disrupt operations.

Carter's Same-Store Sales Growth

2. Mediocre Free Cash Flow Margin Limits Reinvestment Potential

If you’ve followed StockStory for a while, you know we emphasize free cash flow. Why, you ask? We believe that in the end, cash is king, and you can’t use accounting profits to pay the bills.

Carter's has shown poor cash profitability relative to peers over the last two years, giving the company fewer opportunities to return capital to shareholders. Its free cash flow margin averaged 5.4%, below what we’d expect for a consumer discretionary business.

Carter's Trailing 12-Month Free Cash Flow Margin

3. New Investments Fail to Bear Fruit as ROIC Declines

We like to invest in businesses with high returns, but the trend in a company’s ROIC is what often surprises the market and moves the stock price. Unfortunately, Carter’s ROIC has decreased significantly over the last few years. Paired with its already low returns, these declines suggest its profitable growth opportunities are few and far between.

Carter's Trailing 12-Month Return On Invested Capital

Final Judgment

Carter's falls short of our quality standards. With its shares outperforming the market lately, the stock trades at 11.3× forward P/E (or $34.80 per share). This valuation multiple is fair, but we don’t have much confidence in the company. There are better stocks to buy right now. Let us point you toward the Amazon and PayPal of Latin America.

Stocks We Would Buy Instead of Carter's

ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.

Find out which 5 stocks it's flagging for this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  248.65
-0.37 (-0.15%)
AAPL  265.69
+6.86 (2.65%)
AMD  256.84
+1.77 (0.69%)
BAC  54.27
+0.92 (1.73%)
GOOG  333.35
+2.77 (0.84%)
META  673.12
+10.63 (1.60%)
MSFT  411.99
+18.88 (4.80%)
NVDA  198.20
+1.69 (0.86%)
ORCL  170.72
+7.72 (4.74%)
TSLA  393.62
+29.43 (8.08%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.